Predictors of Stroke in Patients With Impaired Glucose Tolerance: Results From the Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research Trial

Risk factors for stroke are well-established in general populations but sparsely studied in individuals with impaired glucose tolerance. We identified predictors of stroke among participants with impaired glucose tolerance in the Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Resea...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Stroke (1970) 2013-09, Vol.44 (9), p.2590-2593
Hauptverfasser:	PREISS, David, GILES, Thomas D, CHIANG, Fu-Tien, MCMURRAY, John J. V, CALIFF, Robert M, THOMAS, Laine E, SUN, Jie-Lena, HAFFNER, Steven M, HOLMAN, Rury R, STANDL, Eberhard, MAZZONE, Theodore, RUTTEN, Guy E, TOGNONI, Gianni
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Antihypertensive Agents - therapeutic use Biological and medical sciences Comorbidity Controlled Clinical Trials as Topic Cyclohexanes - therapeutic use Drug Therapy, Combination Female Glucose Intolerance - drug therapy Glucose Intolerance - epidemiology Headache. Facial pains. Syncopes. Epilepsia. Intracranial hypertension. Brain oedema. Cerebral palsy Humans Hypoglycemic Agents - therapeutic use Male Medical sciences Middle Aged Nervous system (semeiology, syndromes) Neurology Outcome Assessment (Health Care) Phenylalanine - analogs & derivatives Phenylalanine - therapeutic use Predictive Value of Tests Risk Factors Stroke - epidemiology Stroke - etiology Tetrazoles - therapeutic use Valine - analogs & derivatives Valine - therapeutic use Valsartan Vascular diseases and vascular malformations of the nervous system
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!